Form 13-F position report

BLUEBIRD BIO INC COM STK NEW (

Reported by STATE STREET CORPORATION

BLUE CUSIP 09609G209 Manager CIK 0000093751

Reported 0 shares, down 196,179 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 48 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 76097000
2022-03-31 63787000
2022-06-30 7556000
2022-09-30 80521000
2022-12-31 88295539
2023-03-31 56494436
2023-06-30 53818248
2023-09-30 38501953
2023-12-31 19134692
2024-03-31 4388013
2024-06-30 3738524
2024-09-30 1995879
2024-12-31 0
2024-12-31 1650661
2025-03-31 957354
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for BLUEBIRD BIO INC COM STK NEW ( held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -196,179 (-100.0%) 0 $0 2025-08-14
Q1 2025 Reduced 196,179 -1,742 (-0.9%) < 0.01% $957,354 2025-05-15
Q4 2024 New 197,921 +197,921 (0.0%) < 0.01% $1,650,661 2025-02-14
Q4 2024 Reduced 0 -3,841,923 (-100.0%) 0 $0 2025-02-14
Q3 2024 Added 3,841,923 +43,382 (1.1%) < 0.01% $1,995,879 2024-11-14
Q2 2024 Added 3,798,541 +370,406 (10.8%) < 0.01% $3,738,524 2024-08-14
Q1 2024 Reduced 3,428,135 -10,437,584 (-75.3%) < 0.01% $4,388,013 2024-05-15
Q4 2023 Added 13,865,719 +1,200,603 (9.5%) < 0.01% $19,134,692 2024-02-14
Q3 2023 Reduced 12,665,116 -3,693,014 (-22.6%) < 0.01% $38,501,953 2023-11-14
Q2 2023 Reduced 16,358,130 -1,407,416 (-7.9%) < 0.01% $53,818,248 2023-08-14
Q1 2023 Added 17,765,546 +5,006,075 (39.2%) < 0.01% $56,494,436 2023-05-15
Q4 2022 Added 12,759,471 +38,991 (0.3%) < 0.01% $88,295,539 2023-02-14
Q3 2022 Added 12,720,480 +10,895,379 (597.0%) < 0.01% $80,521,000 2022-11-15
Q2 2022 Reduced 1,825,101 -11,326,790 (-86.1%) < 0.01% $7,556,000 2022-08-15
Q1 2022 Added 13,151,891 +5,534,581 (72.7%) < 0.01% $63,787,000 2022-05-16
Q4 2021 Added 7,617,310 +3,147,374 (70.4%) < 0.01% $76,097,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

87 managers reported BLUEBIRD BIO INC COM STK NEW ( for Q2 2025.

Managers reporting BLUEBIRD BIO INC COM STK NEW ( in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Russell Investments Group Ltd Added 1,386 +1,278 < 0.01% $6,888 2 qtrs
Barclays PLC Reduced 1 -9,812 < 0.01% $4 3 qtrs
IFP Advisors Inc New 7 +7 < 0.01% $3 3 qtrs
JPMorgan Chase & Co Reduced 0 -26,870 0 $0 3 qtrs
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM Reduced 0 -694 0 $0 3 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 0 -5,476 0 $0 3 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 3 qtrs
MORGAN STANLEY Reduced 0 -28,723 0 $0 3 qtrs
Quinn Opportunity Partners LLC Reduced 0 -81,429 0 $0 2 qtrs
Bank of America Corporation Reduced 0 -26,224 0 $0 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 14, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.